PMID- 33774866 OWN - NLM STAT- MEDLINE DCOM- 20210719 LR - 20210719 IS - 1530-6860 (Electronic) IS - 0892-6638 (Linking) VI - 35 IP - 5 DP - 2021 May TI - TUFM is involved in Alzheimer's disease-like pathologies that are associated with ROS. PG - e21445 LID - 10.1096/fj.202002461R [doi] AB - Mitochondrial Tu translation elongation factor (TUFM or EF-Tu) is part of the mitochondrial translation machinery. It is reported that TUFM expression is reduced in the brain of Alzheimer's disease (AD), suggesting that TUFM might play a role in the pathophysiology. In this study, we found that TUFM protein level was decreased in the hippocampus and cortex especially in the aged APP/PS1 mice, an animal model of AD. In HEK cells that stably express full-length human amyloid-beta precursor protein (HEK-APP), TUFM knockdown or overexpression increased or reduced the protein levels of beta-amyloid protein (Abeta) and beta-amyloid converting enzyme 1 (BACE1), respectively. TUFM-mediated reduction of BACE1 was attenuated by translation inhibitor cycloheximide (CHX) or alpha-[2-[4-(3,4-Dichlorophenyl)-2-thiazolyl]hydrazinylidene]-2-nitro-benzenepropanoic acid (4EGI1), and in cells overexpressing BACE1 constructs deleting the 5' untranslated region (5'UTR). TUFM silencing increased the half-life of BACE1 mRNA, suggesting that RNA stability was affected by TUFM. In support, transcription inhibitor Actinomycin D (ActD) and silencing of nuclear factor kappaB (NFkappaB) failed to abolish TUFM-mediated regulation of BACE1 protein and mRNA. We further found that the mitochondria-targeted antioxidant TEMPO diminished the effects of TUFM on BACE1, suggesting that reactive oxygen species (ROS) played an important role. Indeed, cellular ROS levels were affected by TUFM knockdown or overexpression, and TUFM-mediated regulation of apoptosis and Tau phosphorylation at selective sites was attenuated by TEMPO. Collectively, TUFM protein levels were decreased in APP/PS1 mice. TUFM is involved in AD pathology by regulating BACE1 translation, apoptosis, and Tau phosphorylation, in which ROS plays an important role. CI - (c) 2021 Federation of American Societies for Experimental Biology. FAU - Zhong, Bi-Rou AU - Zhong BR AD - Department of Neurology, the First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Neurology, Chongqing, China. FAU - Zhou, Gui-Feng AU - Zhou GF AD - Department of Neurology, the First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Neurology, Chongqing, China. FAU - Song, Li AU - Song L AD - Department of Neurology, the First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Neurology, Chongqing, China. FAU - Wen, Qi-Xin AU - Wen QX AD - Department of Neurology, the First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Neurology, Chongqing, China. FAU - Deng, Xiao-Juan AU - Deng XJ AD - Department of Neurology, the First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Neurology, Chongqing, China. FAU - Ma, Yuan-Lin AU - Ma YL AD - Department of Neurology, the First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Neurology, Chongqing, China. FAU - Hu, Li-Tian AU - Hu LT AD - Department of Neurology, the First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Neurology, Chongqing, China. AD - Department of Neurology, Nanchong Central Hospital, the Second Clinical College of North Sichuan Medical College, Nanchong, China. FAU - Chen, Guo-Jun AU - Chen GJ AD - Department of Neurology, the First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Neurology, Chongqing, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - FASEB J JT - FASEB journal : official publication of the Federation of American Societies for Experimental Biology JID - 8804484 RN - 0 (Amyloid beta-Protein Precursor) RN - 0 (Presenilin-1) RN - 0 (Reactive Oxygen Species) RN - EC 3.4.- (Amyloid Precursor Protein Secretases) RN - EC 3.6.1.- (Peptide Elongation Factor Tu) SB - IM MH - Alzheimer Disease/genetics/metabolism/*pathology MH - Amyloid Precursor Protein Secretases/genetics/*metabolism MH - Amyloid beta-Protein Precursor/physiology MH - Animals MH - *Disease Models, Animal MH - Humans MH - Mice MH - Mice, Transgenic MH - Mitochondria/metabolism/*pathology MH - Peptide Elongation Factor Tu/genetics/*metabolism MH - Phosphorylation MH - Presenilin-1/physiology MH - Reactive Oxygen Species/*metabolism OTO - NOTNLM OT - BACE1 translation OT - RNA stability OT - ROS OT - TUFM OT - Tau OT - apoptosis OT - beta-amyloid protein EDAT- 2021/03/29 06:00 MHDA- 2021/07/20 06:00 CRDT- 2021/03/28 21:13 PHST- 2021/01/20 00:00 [revised] PHST- 2020/11/06 00:00 [received] PHST- 2021/02/01 00:00 [accepted] PHST- 2021/03/28 21:13 [entrez] PHST- 2021/03/29 06:00 [pubmed] PHST- 2021/07/20 06:00 [medline] AID - 10.1096/fj.202002461R [doi] PST - ppublish SO - FASEB J. 2021 May;35(5):e21445. doi: 10.1096/fj.202002461R.